stars 1 stars 2 stars 3

Orbit Pharma is a rapidly expanding, privately owned company focused on the development and marketing of high quality, specialist generic medicines across the UK, Europe, ANZ, Canada, US and globally. Orbit Pharma develops, manufactures and supplies cost effective complex medicines that allows better access to medicines for patients across the world. A unique combination of a scientific, medical background backed up by longstanding, high-quality physician expertise, comprehensive pharmaceutical industrial drug development experience and regulatory agency licensing expertise. We are supported by specific business and management qualified, experienced as well as well trained people. We are specialised in oral solids, oral liquids, semi-solids and injectable formulation categories. Orbit Pharma believes and look forward to mutually beneficial relationship. We can to achieve success in partnership and business synergy.

Orbit Pharma Questions

The Orbit Pharma annual revenue was $2.4 million in 2026.

14 people are employed at Orbit Pharma.

The NAICS codes for Orbit Pharma are [32, 3254, 32541, 325].

The SIC codes for Orbit Pharma are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users